University of Birmingham academic and leading haematologist Professor Paul Moss has been awarded an OBE in the 2022 Queen’s Birthday Honours for services to immunotherapy and COVID-19 research.
Professor Moss is a distinguished clinical haematologist who, through his leadership in research, has made huge contributions to UK science. Recognised nationally and internationally for building a world-class centre for a haematological research, clinical training and patient care in Birmingham, he is a pioneer in treating viral infections and blood cancers by harnessing the power of the body’s immune system.
It is a great honour to receive this award and it reflects the magnificent contribution that has been made over the last two years by my laboratory colleagues with support from across the University.Professor Paul Moss
Professor Moss led the UK Coronavirus Immunology Consortium (UK-CIC) that brought together top immunologists from 20 UK universities to understand the immune response to COVID-19. Launched in August 2020 with £6.5 million funding from UKRI and NIHR, the consortium’s outputs defined long-lived anti-COVID immunity, identified new targets for treatment and made clear the mechanisms by which variants of the virus evade the immune system.
Most recently, Professor Moss has been leading the immunity strand of the COVID-19 National Core Studies Programme, initiated by Sir Patrick Vallance in October 2020, which supports research to improve understanding of immunity against COVID-19 in order to guide UK health policy.
Internationally, he chairs WHO’s Immunomodulatory Advisory Group, which recommended four new drugs for inclusion in the international WHO SOLIDARITY trial involving 14,000 COVID patients in over 43 countries.
On hearing news of his award, he commented: ‘It is a great honour to receive this award and it reflects the magnificent contribution that has been made over the last two years by my laboratory colleagues with support from across the University.
‘We are delighted that we have been able to contribute to understanding how to optimise immune protection against COVID-19 for vulnerable people, and it feels very special to receive the award at the time of the Platinum Jubilee.”